line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,0.0,VALIANTLAB.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.3,VALIANTLAB.NS
Normalized EBITDA,2025-03-31 00:00:00,7553000.0,VALIANTLAB.NS
Total Unusual Items,2025-03-31 00:00:00,0.0,VALIANTLAB.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,0.0,VALIANTLAB.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,-22012000.0,VALIANTLAB.NS
Reconciled Depreciation,2025-03-31 00:00:00,20926000.0,VALIANTLAB.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,1165998000.0,VALIANTLAB.NS
EBITDA,2025-03-31 00:00:00,7553000.0,VALIANTLAB.NS
EBIT,2025-03-31 00:00:00,-13373000.0,VALIANTLAB.NS
Net Interest Income,2025-03-31 00:00:00,-1753000.0,VALIANTLAB.NS
Interest Expense,2025-03-31 00:00:00,1753000.0,VALIANTLAB.NS
Interest Income,2025-03-31 00:00:00,,VALIANTLAB.NS
Normalized Income,2025-03-31 00:00:00,-22012000.0,VALIANTLAB.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,-22012000.0,VALIANTLAB.NS
Total Expenses,2025-03-31 00:00:00,1401540000.0,VALIANTLAB.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,VALIANTLAB.NS
Diluted Average Shares,2025-03-31 00:00:00,,VALIANTLAB.NS
Basic Average Shares,2025-03-31 00:00:00,,VALIANTLAB.NS
Diluted EPS,2025-03-31 00:00:00,,VALIANTLAB.NS
Basic EPS,2025-03-31 00:00:00,,VALIANTLAB.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,-22012000.0,VALIANTLAB.NS
Net Income Common Stockholders,2025-03-31 00:00:00,-22012000.0,VALIANTLAB.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,VALIANTLAB.NS
Net Income,2025-03-31 00:00:00,-22012000.0,VALIANTLAB.NS
Minority Interests,2025-03-31 00:00:00,,VALIANTLAB.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,-22012000.0,VALIANTLAB.NS
Net Income Continuous Operations,2025-03-31 00:00:00,-22012000.0,VALIANTLAB.NS
Tax Provision,2025-03-31 00:00:00,6886000.0,VALIANTLAB.NS
Pretax Income,2025-03-31 00:00:00,-15126000.0,VALIANTLAB.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,54348000.0,VALIANTLAB.NS
Special Income Charges,2025-03-31 00:00:00,0.0,VALIANTLAB.NS
Other Special Charges,2025-03-31 00:00:00,,VALIANTLAB.NS
Write Off,2025-03-31 00:00:00,,VALIANTLAB.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-1753000.0,VALIANTLAB.NS
Interest Expense Non Operating,2025-03-31 00:00:00,1753000.0,VALIANTLAB.NS
Interest Income Non Operating,2025-03-31 00:00:00,,VALIANTLAB.NS
Operating Income,2025-03-31 00:00:00,-67720000.0,VALIANTLAB.NS
Operating Expense,2025-03-31 00:00:00,235542000.0,VALIANTLAB.NS
Other Operating Expenses,2025-03-31 00:00:00,170735000.0,VALIANTLAB.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,20926000.0,VALIANTLAB.NS
Depreciation Income Statement,2025-03-31 00:00:00,20926000.0,VALIANTLAB.NS
Selling General And Administration,2025-03-31 00:00:00,,VALIANTLAB.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,VALIANTLAB.NS
General And Administrative Expense,2025-03-31 00:00:00,,VALIANTLAB.NS
Rent And Landing Fees,2025-03-31 00:00:00,,VALIANTLAB.NS
Gross Profit,2025-03-31 00:00:00,167822000.0,VALIANTLAB.NS
Cost Of Revenue,2025-03-31 00:00:00,1165998000.0,VALIANTLAB.NS
Total Revenue,2025-03-31 00:00:00,1333820000.0,VALIANTLAB.NS
Operating Revenue,2025-03-31 00:00:00,1333820000.0,VALIANTLAB.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,VALIANTLAB.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.3,VALIANTLAB.NS
Normalized EBITDA,2024-03-31 00:00:00,12739000.0,VALIANTLAB.NS
Total Unusual Items,2024-03-31 00:00:00,0.0,VALIANTLAB.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,0.0,VALIANTLAB.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,3196000.0,VALIANTLAB.NS
Reconciled Depreciation,2024-03-31 00:00:00,19656000.0,VALIANTLAB.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,1682521000.0,VALIANTLAB.NS
EBITDA,2024-03-31 00:00:00,12739000.0,VALIANTLAB.NS
EBIT,2024-03-31 00:00:00,-6917000.0,VALIANTLAB.NS
Net Interest Income,2024-03-31 00:00:00,-778000.0,VALIANTLAB.NS
Interest Expense,2024-03-31 00:00:00,778000.0,VALIANTLAB.NS
Interest Income,2024-03-31 00:00:00,,VALIANTLAB.NS
Normalized Income,2024-03-31 00:00:00,3196000.0,VALIANTLAB.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,3196000.0,VALIANTLAB.NS
Total Expenses,2024-03-31 00:00:00,1924282000.0,VALIANTLAB.NS
Rent Expense Supplemental,2024-03-31 00:00:00,,VALIANTLAB.NS
Diluted Average Shares,2024-03-31 00:00:00,43450000.0,VALIANTLAB.NS
Basic Average Shares,2024-03-31 00:00:00,43450000.0,VALIANTLAB.NS
Diluted EPS,2024-03-31 00:00:00,0.13,VALIANTLAB.NS
Basic EPS,2024-03-31 00:00:00,0.13,VALIANTLAB.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,3196000.0,VALIANTLAB.NS
Net Income Common Stockholders,2024-03-31 00:00:00,3196000.0,VALIANTLAB.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,VALIANTLAB.NS
Net Income,2024-03-31 00:00:00,3196000.0,VALIANTLAB.NS
Minority Interests,2024-03-31 00:00:00,,VALIANTLAB.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,3196000.0,VALIANTLAB.NS
Net Income Continuous Operations,2024-03-31 00:00:00,3196000.0,VALIANTLAB.NS
Tax Provision,2024-03-31 00:00:00,-10891000.0,VALIANTLAB.NS
Pretax Income,2024-03-31 00:00:00,-7695000.0,VALIANTLAB.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,96815000.0,VALIANTLAB.NS
Special Income Charges,2024-03-31 00:00:00,0.0,VALIANTLAB.NS
Other Special Charges,2024-03-31 00:00:00,,VALIANTLAB.NS
Write Off,2024-03-31 00:00:00,,VALIANTLAB.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-778000.0,VALIANTLAB.NS
Interest Expense Non Operating,2024-03-31 00:00:00,778000.0,VALIANTLAB.NS
Interest Income Non Operating,2024-03-31 00:00:00,,VALIANTLAB.NS
Operating Income,2024-03-31 00:00:00,-103710000.0,VALIANTLAB.NS
Operating Expense,2024-03-31 00:00:00,241761000.0,VALIANTLAB.NS
Other Operating Expenses,2024-03-31 00:00:00,178978000.0,VALIANTLAB.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,19656000.0,VALIANTLAB.NS
Depreciation Income Statement,2024-03-31 00:00:00,19656000.0,VALIANTLAB.NS
Selling General And Administration,2024-03-31 00:00:00,,VALIANTLAB.NS
Selling And Marketing Expense,2024-03-31 00:00:00,,VALIANTLAB.NS
General And Administrative Expense,2024-03-31 00:00:00,,VALIANTLAB.NS
Rent And Landing Fees,2024-03-31 00:00:00,,VALIANTLAB.NS
Gross Profit,2024-03-31 00:00:00,138051000.0,VALIANTLAB.NS
Cost Of Revenue,2024-03-31 00:00:00,1682521000.0,VALIANTLAB.NS
Total Revenue,2024-03-31 00:00:00,1820572000.0,VALIANTLAB.NS
Operating Revenue,2024-03-31 00:00:00,1820572000.0,VALIANTLAB.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,0.0,VALIANTLAB.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.239616,VALIANTLAB.NS
Normalized EBITDA,2023-03-31 00:00:00,399532000.0,VALIANTLAB.NS
Total Unusual Items,2023-03-31 00:00:00,0.0,VALIANTLAB.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,0.0,VALIANTLAB.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,289983000.0,VALIANTLAB.NS
Reconciled Depreciation,2023-03-31 00:00:00,15631000.0,VALIANTLAB.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,2773192000.0,VALIANTLAB.NS
EBITDA,2023-03-31 00:00:00,399532000.0,VALIANTLAB.NS
EBIT,2023-03-31 00:00:00,383901000.0,VALIANTLAB.NS
Net Interest Income,2023-03-31 00:00:00,-2537000.0,VALIANTLAB.NS
Interest Expense,2023-03-31 00:00:00,2537000.0,VALIANTLAB.NS
Interest Income,2023-03-31 00:00:00,970000.0,VALIANTLAB.NS
Normalized Income,2023-03-31 00:00:00,289983000.0,VALIANTLAB.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,289983000.0,VALIANTLAB.NS
Total Expenses,2023-03-31 00:00:00,3003820000.0,VALIANTLAB.NS
Rent Expense Supplemental,2023-03-31 00:00:00,210000.0,VALIANTLAB.NS
Diluted Average Shares,2023-03-31 00:00:00,43450000.0,VALIANTLAB.NS
Basic Average Shares,2023-03-31 00:00:00,43450000.0,VALIANTLAB.NS
Diluted EPS,2023-03-31 00:00:00,6.673947,VALIANTLAB.NS
Basic EPS,2023-03-31 00:00:00,6.673947,VALIANTLAB.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,289983000.0,VALIANTLAB.NS
Net Income Common Stockholders,2023-03-31 00:00:00,289983000.0,VALIANTLAB.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,VALIANTLAB.NS
Net Income,2023-03-31 00:00:00,289983000.0,VALIANTLAB.NS
Minority Interests,2023-03-31 00:00:00,0.0,VALIANTLAB.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,289983000.0,VALIANTLAB.NS
Net Income Continuous Operations,2023-03-31 00:00:00,289983000.0,VALIANTLAB.NS
Tax Provision,2023-03-31 00:00:00,91381000.0,VALIANTLAB.NS
Pretax Income,2023-03-31 00:00:00,381364000.0,VALIANTLAB.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,48626000.0,VALIANTLAB.NS
Special Income Charges,2023-03-31 00:00:00,0.0,VALIANTLAB.NS
Other Special Charges,2023-03-31 00:00:00,,VALIANTLAB.NS
Write Off,2023-03-31 00:00:00,2200000.0,VALIANTLAB.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-2537000.0,VALIANTLAB.NS
Interest Expense Non Operating,2023-03-31 00:00:00,2537000.0,VALIANTLAB.NS
Interest Income Non Operating,2023-03-31 00:00:00,970000.0,VALIANTLAB.NS
Operating Income,2023-03-31 00:00:00,335275000.0,VALIANTLAB.NS
Operating Expense,2023-03-31 00:00:00,230628000.0,VALIANTLAB.NS
Other Operating Expenses,2023-03-31 00:00:00,168872000.0,VALIANTLAB.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,15631000.0,VALIANTLAB.NS
Depreciation Income Statement,2023-03-31 00:00:00,15631000.0,VALIANTLAB.NS
Selling General And Administration,2023-03-31 00:00:00,24460000.0,VALIANTLAB.NS
Selling And Marketing Expense,2023-03-31 00:00:00,17930000.0,VALIANTLAB.NS
General And Administrative Expense,2023-03-31 00:00:00,6530000.0,VALIANTLAB.NS
Rent And Landing Fees,2023-03-31 00:00:00,210000.0,VALIANTLAB.NS
Gross Profit,2023-03-31 00:00:00,565903000.0,VALIANTLAB.NS
Cost Of Revenue,2023-03-31 00:00:00,2773192000.0,VALIANTLAB.NS
Total Revenue,2023-03-31 00:00:00,3339095000.0,VALIANTLAB.NS
Operating Revenue,2023-03-31 00:00:00,3339095000.0,VALIANTLAB.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,-330466.142336,VALIANTLAB.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.340687,VALIANTLAB.NS
Normalized EBITDA,2022-03-31 00:00:00,443640000.0,VALIANTLAB.NS
Total Unusual Items,2022-03-31 00:00:00,-970000.0,VALIANTLAB.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,-970000.0,VALIANTLAB.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,274960000.0,VALIANTLAB.NS
Reconciled Depreciation,2022-03-31 00:00:00,24900000.0,VALIANTLAB.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,2392020000.0,VALIANTLAB.NS
EBITDA,2022-03-31 00:00:00,442670000.0,VALIANTLAB.NS
EBIT,2022-03-31 00:00:00,417770000.0,VALIANTLAB.NS
Net Interest Income,2022-03-31 00:00:00,4720000.0,VALIANTLAB.NS
Interest Expense,2022-03-31 00:00:00,730000.0,VALIANTLAB.NS
Interest Income,2022-03-31 00:00:00,5450000.0,VALIANTLAB.NS
Normalized Income,2022-03-31 00:00:00,275599533.857664,VALIANTLAB.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,274960000.0,VALIANTLAB.NS
Total Expenses,2022-03-31 00:00:00,2515180000.0,VALIANTLAB.NS
Rent Expense Supplemental,2022-03-31 00:00:00,0.0,VALIANTLAB.NS
Diluted Average Shares,2022-03-31 00:00:00,43450000.0,VALIANTLAB.NS
Basic Average Shares,2022-03-31 00:00:00,43450000.0,VALIANTLAB.NS
Diluted EPS,2022-03-31 00:00:00,6.328193,VALIANTLAB.NS
Basic EPS,2022-03-31 00:00:00,6.328193,VALIANTLAB.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,274960000.0,VALIANTLAB.NS
Net Income Common Stockholders,2022-03-31 00:00:00,274960000.0,VALIANTLAB.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,VALIANTLAB.NS
Net Income,2022-03-31 00:00:00,274960000.0,VALIANTLAB.NS
Minority Interests,2022-03-31 00:00:00,,VALIANTLAB.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,274960000.0,VALIANTLAB.NS
Net Income Continuous Operations,2022-03-31 00:00:00,274960000.0,VALIANTLAB.NS
Tax Provision,2022-03-31 00:00:00,142080000.0,VALIANTLAB.NS
Pretax Income,2022-03-31 00:00:00,417040000.0,VALIANTLAB.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,4620000.0,VALIANTLAB.NS
Special Income Charges,2022-03-31 00:00:00,-1270000.0,VALIANTLAB.NS
Other Special Charges,2022-03-31 00:00:00,-400000.0,VALIANTLAB.NS
Write Off,2022-03-31 00:00:00,1670000.0,VALIANTLAB.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,4720000.0,VALIANTLAB.NS
Interest Expense Non Operating,2022-03-31 00:00:00,730000.0,VALIANTLAB.NS
Interest Income Non Operating,2022-03-31 00:00:00,5450000.0,VALIANTLAB.NS
Operating Income,2022-03-31 00:00:00,400050000.0,VALIANTLAB.NS
Operating Expense,2022-03-31 00:00:00,123160000.0,VALIANTLAB.NS
Other Operating Expenses,2022-03-31 00:00:00,35000000.0,VALIANTLAB.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,24900000.0,VALIANTLAB.NS
Depreciation Income Statement,2022-03-31 00:00:00,24900000.0,VALIANTLAB.NS
Selling General And Administration,2022-03-31 00:00:00,17450000.0,VALIANTLAB.NS
Selling And Marketing Expense,2022-03-31 00:00:00,12680000.0,VALIANTLAB.NS
General And Administrative Expense,2022-03-31 00:00:00,4770000.0,VALIANTLAB.NS
Rent And Landing Fees,2022-03-31 00:00:00,0.0,VALIANTLAB.NS
Gross Profit,2022-03-31 00:00:00,523210000.0,VALIANTLAB.NS
Cost Of Revenue,2022-03-31 00:00:00,2392020000.0,VALIANTLAB.NS
Total Revenue,2022-03-31 00:00:00,2915230000.0,VALIANTLAB.NS
Operating Revenue,2022-03-31 00:00:00,2915230000.0,VALIANTLAB.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,VALIANTLAB.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,VALIANTLAB.NS
Normalized EBITDA,2021-03-31 00:00:00,,VALIANTLAB.NS
Total Unusual Items,2021-03-31 00:00:00,,VALIANTLAB.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,VALIANTLAB.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,VALIANTLAB.NS
Reconciled Depreciation,2021-03-31 00:00:00,,VALIANTLAB.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,VALIANTLAB.NS
EBITDA,2021-03-31 00:00:00,,VALIANTLAB.NS
EBIT,2021-03-31 00:00:00,,VALIANTLAB.NS
Net Interest Income,2021-03-31 00:00:00,,VALIANTLAB.NS
Interest Expense,2021-03-31 00:00:00,,VALIANTLAB.NS
Interest Income,2021-03-31 00:00:00,3695071.0,VALIANTLAB.NS
Normalized Income,2021-03-31 00:00:00,,VALIANTLAB.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,VALIANTLAB.NS
Total Expenses,2021-03-31 00:00:00,,VALIANTLAB.NS
Rent Expense Supplemental,2021-03-31 00:00:00,0.0,VALIANTLAB.NS
Diluted Average Shares,2021-03-31 00:00:00,43450000.0,VALIANTLAB.NS
Basic Average Shares,2021-03-31 00:00:00,43450000.0,VALIANTLAB.NS
Diluted EPS,2021-03-31 00:00:00,7.040967,VALIANTLAB.NS
Basic EPS,2021-03-31 00:00:00,7.040967,VALIANTLAB.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,VALIANTLAB.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,VALIANTLAB.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,VALIANTLAB.NS
Net Income,2021-03-31 00:00:00,,VALIANTLAB.NS
Minority Interests,2021-03-31 00:00:00,,VALIANTLAB.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,VALIANTLAB.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,VALIANTLAB.NS
Tax Provision,2021-03-31 00:00:00,,VALIANTLAB.NS
Pretax Income,2021-03-31 00:00:00,,VALIANTLAB.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,VALIANTLAB.NS
Special Income Charges,2021-03-31 00:00:00,,VALIANTLAB.NS
Other Special Charges,2021-03-31 00:00:00,,VALIANTLAB.NS
Write Off,2021-03-31 00:00:00,0.0,VALIANTLAB.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,VALIANTLAB.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,VALIANTLAB.NS
Interest Income Non Operating,2021-03-31 00:00:00,3695071.0,VALIANTLAB.NS
Operating Income,2021-03-31 00:00:00,,VALIANTLAB.NS
Operating Expense,2021-03-31 00:00:00,,VALIANTLAB.NS
Other Operating Expenses,2021-03-31 00:00:00,,VALIANTLAB.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,VALIANTLAB.NS
Depreciation Income Statement,2021-03-31 00:00:00,,VALIANTLAB.NS
Selling General And Administration,2021-03-31 00:00:00,11840000.0,VALIANTLAB.NS
Selling And Marketing Expense,2021-03-31 00:00:00,6290000.0,VALIANTLAB.NS
General And Administrative Expense,2021-03-31 00:00:00,5550000.0,VALIANTLAB.NS
Rent And Landing Fees,2021-03-31 00:00:00,0.0,VALIANTLAB.NS
Gross Profit,2021-03-31 00:00:00,,VALIANTLAB.NS
Cost Of Revenue,2021-03-31 00:00:00,,VALIANTLAB.NS
Total Revenue,2021-03-31 00:00:00,,VALIANTLAB.NS
Operating Revenue,2021-03-31 00:00:00,,VALIANTLAB.NS
